PACB
Price
$2.11
Change
+$0.05 (+2.43%)
Updated
Oct 23 closing price
Capitalization
655.85M
11 days until earnings call
Intraday BUY SELL Signals
QSI
Price
$1.40
Change
+$0.25 (+21.74%)
Updated
Oct 23 closing price
Capitalization
306.44M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PACB vs QSI

PACB vs QSI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PACB vs. QSI commentary
Oct 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACB is a Buy and QSI is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PACB with price predictions
Oct 23, 2026

PACB in downward trend: price expected to drop as it breaks its higher Bollinger Band on October 05, 2026

PACB broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 49 similar instances where the stock broke above the upper band. In 46 of the 49 cases the stock fell afterwards. This puts the odds of success at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for PACB moved out of overbought territory on October 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 26 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.

The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PACB as a result. In 74 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for PACB turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 39 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PACB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 66 cases where PACB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

PACB moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PACB crossed bullishly above the 50-day moving average on September 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

The 50-day moving average for PACB moved above the 200-day moving average on October 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +16.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where PACB advanced for three days, in 221 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

The Aroon Indicator entered an Uptrend today. In 117 of 138 cases where PACB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. PACB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PACB's P/B Ratio (-19.747) is slightly lower than the industry average of (2.914). P/E Ratio (-5.024) is within average values for comparable stocks, (1.904). PACB's Projected Growth (PEG Ratio) (180.110) is very high in comparison to the industry average of (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.565) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PACB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for QSI with price predictions
Oct 23, 2026

QSI's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for QSI moved out of overbought territory on October 12, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 instances where the indicator moved out of the overbought zone. In 24 of the 26 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QSI as a result. In 81 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

The Moving Average Convergence Divergence Histogram (MACD) for QSI turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 41 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

QSI broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 64 cases where QSI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

QSI moved above its 50-day moving average on September 24, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for QSI crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

The 50-day moving average for QSI moved above the 200-day moving average on October 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +12.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where QSI advanced for three days, in 156 of 196 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 96 of 122 cases where QSI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.701) is normal, around the industry mean (2.914). P/E Ratio (-3.043) is within average values for comparable stocks, (1.904). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (100.000) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. QSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
PACB vs QSI: Fundamental Ratings
PACB
QSI
OUTLOOK RATING
1..100
9192
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3536
P/E GROWTH RATING
1..100
9195
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QSI's Valuation (31) in the null industry is significantly better than the same rating for PACB (98) in the Biotechnology industry. This means that QSI’s stock grew significantly faster than PACB’s over the last 12 months.

QSI's Profit vs Risk Rating (100) in the null industry is in the same range as PACB (100) in the Biotechnology industry. This means that QSI’s stock grew similarly to PACB’s over the last 12 months.

QSI's SMR Rating (98) in the null industry is in the same range as PACB (100) in the Biotechnology industry. This means that QSI’s stock grew similarly to PACB’s over the last 12 months.

PACB's Price Growth Rating (35) in the Biotechnology industry is in the same range as QSI (36) in the null industry. This means that PACB’s stock grew similarly to QSI’s over the last 12 months.

PACB's P/E Growth Rating (91) in the Biotechnology industry is in the same range as QSI (95) in the null industry. This means that PACB’s stock grew similarly to QSI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PACBQSI
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
COMPARISON
Comparison
Oct 24, 2026
Stock price -- (PACB: $2.11 vs. QSI: $1.40)
Brand notoriety: PACB and QSI are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: PACB: 44% vs. QSI: 182%
Market capitalization -- PACB: $655.85M vs. QSI: $306.44M
PACB [@Medical/Nursing Services] is valued at $655.85M. QSI’s [@Medical/Nursing Services] market capitalization is $306.44M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $179.44B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PACB’s FA Score shows that 0 FA rating(s) are green while QSI’s FA Score has 1 green FA rating(s).

  • PACB’s FA Score: 0 green, 5 red.
  • QSI’s FA Score: 1 green, 4 red.
According to our system of comparison, QSI is a better buy in the long-term than PACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PACB’s TA Score shows that 6 TA indicator(s) are bullish while QSI’s TA Score has 6 bullish TA indicator(s).

  • PACB’s TA Score: 6 bullish, 5 bearish.
  • QSI’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, PACB is a better buy in the short-term than QSI.

Price Growth

PACB (@Medical/Nursing Services) experienced а +21.97% price change this week, while QSI (@Medical/Nursing Services) price change was +25.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.51%. For the same industry, the average monthly price growth was -9.72%, and the average quarterly price growth was -10.64%.

Reported Earning Dates

PACB is expected to report earnings on Nov 04, 2026.

QSI is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-0.51% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
PACB
Daily Signal:
Gain/Loss:
QSI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

PACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PACB has been loosely correlated with TXG. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PACB jumps, then TXG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PACB
1D Price
Change %
PACB100%
+2.43%
TXG - PACB
52%
Loosely correlated
+2.58%
BFLY - PACB
52%
Loosely correlated
-0.73%
ILMN - PACB
48%
Loosely correlated
+0.01%
QSI - PACB
47%
Loosely correlated
+21.74%
MASS - PACB
46%
Loosely correlated
+1.23%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CACI633.9814.76
+2.38%
Caci International CLA
ABTS1.190.01
+0.85%
Abits Group Inc
AKR18.78N/A
N/A
Acadia Realty Trust
ITIC281.73-6.33
-2.20%
Investors Title Company
WYHG2.46-0.14
-5.38%
Wing Yip Food Holdings Group Limited